Foghorn Therapeutics Inc. (FHTX)
undefined
undefined%
At close: undefined
5.30
-0.38%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 34.16M 19.23M 1.32M 430.00K - -
Cost of Revenue 109.69M 19.23K 7.51M 57.72M 1.79M 379.00K
Gross Profit -75.53M 19.21M -6.20M -57.28M -1.79M -379.00K
Operating Income -107.91M -117.14M -100.73M -68.53M -51.08M -26.05M
Interest Income 10.88M 5.67M 2.55M 1.00M 495.00K 113.00K
Pretax Income -94.20M -108.88M -101.32M -68.80M -51.13M -26.34M
Net Income -98.43M -108.87M -103.23M -69.78M -51.67M -26.34M
Selling & General & Admin 32.37M 30.75M 21.73M 11.25M 6.72M 4.82M
Research & Development 109.69M 105.62M 80.33M 57.72M 44.36M 21.23M
Other Expenses - 8.26M 2.49M - - -
Operating Expenses 142.06M 136.37M 102.05M 68.96M 51.08M 26.05M
Interest Expense - - 1.91M 979.00K 540.00K 371.00K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 142.06M 136.37M 102.05M 68.96M 51.08M 26.05M
Income Tax 4.23M -8.26K 1.91M 979.00K 540.00K 83.00K
Shares Outstanding (Basic) 41.97M 41.59M 37.17M 36.79M 36.82M 19.63M
Shares Outstanding (Diluted) 41.97M 41.59M 37.17M 36.79M 36.82M 19.63M
EPS (Basic) -2.34 -2.62 -2.78 -1.9 -1.4 -1.34
EPS (Diluted) -2.34 -2.62 -2.78 -1.9 -1.4 -1.34
EBITDA -104.45M -113.82M -96.19M -66.49M -48.80M -25.59M
Depreciation & Amortization 3.45M 7.90M 7.51M 5.53M 1.79M 379.00K